SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-406363
Filing Date
2014-11-10
Accepted
2014-11-10 17:21:12
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d792036d10q.htm 10-Q 404685
2 EX-31.1 d792036dex311.htm EX-31.1 7621
3 EX-31.2 d792036dex312.htm EX-31.2 7611
4 EX-32.1 d792036dex321.htm EX-32.1 4509
  Complete submission text file 0001193125-14-406363.txt   3440682

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20140930.xml EX-101.INS 397662
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20140930.xsd EX-101.SCH 42296
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20140930_cal.xml EX-101.CAL 50859
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20140930_def.xml EX-101.DEF 88734
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20140930_lab.xml EX-101.LAB 304628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20140930_pre.xml EX-101.PRE 212261
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 141209872
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences